In addition to its role in clinical epidemiology, the Women's Interagency HIV Study (WIHS) conducts high quality pathogenesis research, and is a unique resource for research because of the depth of data and specimens available from each study visit.

The original Women's Interagency HIV Study (WIHS) collected and stored a variety of biological specimens. Inventory may be housed at the national level, or a subset at the local level. The now combined MACS-WIHS Combined Cohort Study (MWCCS) Data Analysis and Coordinating Center (DACC) coordinates and facilitates completion of specimen requests,

The Human Tissue and Organ Research Resource (HTORR) provides high-quality human biospecimens to investigators to facilitate scientific advances in biomedical research across multiple disciplines. HTORR collaborates with a nationwide network of organ procurement organizations, tissue banks, eye banks, and surgical medical centers to recover and distribute a wide variety of human biospecimens from post-surgery and post-mortem donors.

The Vaccine and Treatment Evaluation Units (VTEUs), supported by the Division of Microbiology and Infectious Diseases (DMID) since the 1960s, provide a ready resource for the conduct of clinical trials to evaluate promising vaccines, treatments, and diagnostics for infectious diseases. The sites are part of DMID's Infectious Diseases Clinical Research Consortium (IDCRC).

A common data model for sharing observational HIV data has been developed by the International epidemiology Databases to Evaluate AIDS (IeDEA). The IeDEA DES is used by the seven operational regions of IeDEA to exchange data with each other for collaborative research studies. The IeDEA DES is collaborative work with the international HICDEP standards for HIV observational databases. Anyone is welcome to download the IeDEA DES and use it to structure their data.

The HVTN shares data and specimens collected in its studies with investigators who would like to use our materials to answer research questions related to vaccinology, immunology, or HIV/AIDS. These studies are called ancillary/exploratory studies, and the Network invites any researchers to do these studies because it is our belief that collaborative science benefits everyone, including the community.

HVTN provides structured mentorship and project funding to investigators working on HIV vaccines.

The RSC Public Website, run by the DAIDS Regulatory Support Center (RSC) contractor, has been used in the DAIDS community for over 10 years and is a primary platform to communicate updates to templates, process changes, and other information needed by the RSC research community.

Website resources include: DAIDS policies, manuals and other guidelines and standards, process tutorials, reports and information specific to task areas, relevant contact information, and external links.

The WRCEVA program maintains the Emerging Viruses and Arboviruses Reference Collection and provides reagents and support for investigations of virus outbreaks throughout the world. 

The Vaccine Development Services program offers a collection of preclinical services to support the development of vaccines intended for use in the investigation, control, prevention, and treatment of a wide range of infectious agents (other than HIV).

This is one of several programs provided by NIAID's Division of Microbiology and Infectious Diseases to support infectious disease product developers.